ONESOURCE SPECIALTY PHARMA LTD
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clini… Read more
Market Cap & Net Worth: ONESOURCE SPECIALTY PHARMA LTD (ONESOURCE)
ONESOURCE SPECIALTY PHARMA LTD (NSE:ONESOURCE) has a market capitalization of $1.95 Billion (₹168.68 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #6611 globally and #232 in its home market, demonstrating a -0.16% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ONESOURCE SPECIALTY PHARMA LTD's stock price ₹1471.60 by its total outstanding shares 114621201 (114.62 Million).
ONESOURCE SPECIALTY PHARMA LTD Market Cap History: 2025 to 2026
ONESOURCE SPECIALTY PHARMA LTD's market capitalization history from 2025 to 2026. Data shows growth from $2.40 Billion to $1.95 Billion (0.00% CAGR).
ONESOURCE SPECIALTY PHARMA LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ONESOURCE SPECIALTY PHARMA LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
ONESOURCE SPECIALTY PHARMA LTD's market cap is 0.17 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $2.40 Billion | $14.45 Billion | -$2.10 Million | 0.17x | N/A |
Competitor Companies of ONESOURCE by Market Capitalization
Companies near ONESOURCE SPECIALTY PHARMA LTD in the global market cap rankings as of March 19, 2026.
Key companies related to ONESOURCE SPECIALTY PHARMA LTD by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ONESOURCE SPECIALTY PHARMA LTD Historical Marketcap From 2025 to 2026
Between 2025 and today, ONESOURCE SPECIALTY PHARMA LTD's market cap moved from $2.40 Billion to $ 1.95 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹1.95 Billion | -18.72% |
| 2025 | ₹2.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of ONESOURCE SPECIALTY PHARMA LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.95 Billion USD |
| MoneyControl | $1.95 Billion USD |
| MarketWatch | $1.95 Billion USD |
| marketcap.company | $1.95 Billion USD |
| Reuters | $1.95 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.